Clinical Trials Browser

Terminated × denileukin diftitox × Gynecologic × Clear all

NCT01773889 2018-04-10

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Phase 2 Terminated

2 enrolled 5 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms